AstraZeneca Invests $2 Billion in Summit Therapeutics
MIAMI — September 28, 2026 Summit Therapeutics Inc. announced that AstraZeneca will make a $2 billion strategic equity investment...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MIAMI — September 28, 2026 Summit Therapeutics Inc. announced that AstraZeneca will make a $2 billion strategic equity investment...
TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...
SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...
SAN DIEGO — September 9, 2026 Kura Oncology, Inc. announced the launch of Caspian Therapeutics, Inc., a separately financed...
SAN CARLOS, Calif., August 13, 2026 Biomea Fusion, Inc. announced that the first participant has been dosed in a...
CHICAGO, June 10, 2026 Syntax Bio announced a research and development collaboration with Mayo Clinic to accelerate the development...
